Pallidal hyperdopaminergic innervation underlying d2 receptor-dependent behavioral deficits in the schizophrenia animal model established by EGF

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Sotoyama, Hidekazu ^a   Zheng, Yingjun ^a   Iwakura, Yuriko ^a   Mizuno, Makoto ^a   Aizawa, Miho ^a   Shcherbakova, Ksenia ^a   Wang, Ran ^a   Namba, Hisaaki ^a   Nawa, Hiroyuki ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND; QUINPIROLE; RACLOPRIDE; RESERPINE; RISPERIDONE; TYROSINE 3 MONOOXYGENASE; BIOLOGICAL MARKER; NEUROLEPTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CATALEPSY; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; GLOBUS PALLIDUS; LOCOMOTION; MALE; NEWBORN PERIOD; NONHUMAN; PATHOPHYSIOLOGY; PERINATAL PERIOD; PHARMACOLOGICAL PROCEDURES; PREPULSE INHIBITION; RAT; SCHIZOPHRENIA; AGING; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG ANTAGONISM; EXTRACELLULAR SPACE; HUMAN; HUMAN RELATION; IMMUNOHISTOCHEMISTRY; METABOLISM; MOTOR ACTIVITY; NEWBORN; PATHOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALIA; RATTUS;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CATALEPSY; DISEASE MODELS, ANIMAL; DOPAMINE; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SPACE; GLOBUS PALLIDUS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERPERSONAL RELATIONS; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RESERPINE; RISPERIDONE; SCHIZOPHRENIA; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

EID: 80053957614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025831     Document Type: Article

References (76)

1. Woo RS, Li XM, Tao Y, Carpenter-Hyland E, Huang YZ, et al. (2007) Neuregulin-1 enhances depolarization-induced GABA release. Neuron 54: 599-610.
2. Nagano T, Namba H, Abe Y, Aoki H, Takei N, et al. (2007) In vivo administration of epidermal growth factor and its homologue attenuates developmental maturation of functional excitatory synapses in cortical GABAergic neurons. Eur J Neurosci 25: 380-390.
3. Fazzari P, Paternain AV, Valiente M, Pla R, Luján R, et al. (2010) Control of cortical GABA circuitry development by Nrg1 and ErbB4 signaling. Nature 464: 1376-1380.
4. Kato T, Abe Y, Sotoyama H, Kakita A, Kominami R, et al. (2011) Transient exposure of neonatal mice to neuregulin-1 results in hyperdopaminergic states in adulthood: implication in neurodevelopmental hypothesis for schizophrenia. Mol Psychiatry 16: 307-320.
5. Iwakura Y, Zheng YJ, Sibilia M, Abe Y, Piao YS, et al. (2011) Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1). J Neurochem 118: 45-56.
6. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al. (2001) Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71: 877-892.
7. Munafò MR, Thiselton DL, Clark TG, Flint J, (2006) Association of the NRG1 gene and schizophrenia: a meta-analysis. Mol Psychiatry 11: 539-546.
8. Anttila S, Illi A, Kampman O, Mattila KM, Lehtimäki T, et al. (2004) Association of EGF polymorphism with schizophrenia in Finnish men. Neuroreport 15: 1215-1218.
9. Benzel I, Bansal A, Browning BL, Galwey NW, Maycox PR, et al. (2007) Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 3: 31.
10. Futamura T, Toyooka K, Iritani S, Niizato K, Nakamura R, et al. (2002) Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry 7: 673-682.
11. Shibuya M, Komi E, Wang R, Kato T, Watanabe Y, et al. (2010) Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism. J Neural Transm 117: 887-895.
12. Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, et al. (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 100: 270-280.
13. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, et al. (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 9: 299-307.
14. Zscheppang K, Korenbaum E, Bueter W, Ramadurai SM, Nielsen HC, et al. (2006) ErbB receptor dimerization, localization, and co-localization in mouse lung type II epithelial cells. Pediatr Pulmonol 41: 1205-1212.
15. Yarden Y, Sliwkowski MX, (2001) Untangling the ErbB signaling network. Nat Rev Mol Cell Biol 2: 127-137.
16. Mei L, Xiong WC, (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 9: 437-452.
17. Harrison PJ, Law AJ, (2006) Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 60: 132-140.
18. Patterson PH, (2007) Maternal effects on schizophrenia risk. Science 318: 576-577.
19. Boksa P, (2010) Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 24: 881-897.
20. Meyer U, Feldon J, Fatemi SH, (2009) In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 33: 1061-1079.
21. Ehninger D, Sano Y, de Vries PJ, Dies K, Franz D, et al. (2010) Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry (doi: 10.1038/mp.2010.115) in press.
22. Varner MW, Dildy GA, Hunter C, Dudley DJ, Clark SL, et al. (1996) Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies. J Soc Gynecol Investig 3: 17-19.
23. Hofmann GE, Abramowicz JS, (1990) Epidermal growth factor (EGF) concentrations in amniotic fluid and maternal urine during pregnancy. Acta Obstet Gynecol Scand 69: 217-221.
24. Virgintino D, Maiorano E, Errede M, Vimercati A, Greco P, et al. (1998) Astroglia-microvessel relationship in the developing human telencephalon. Int J Dev Biol 42: 1165-1168.
25. Nawa H, Takei N, (2006) Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res 56: 2-13.
26. Futamura T, Kakita A, Tohmi M, Sotoyama H, Takahashi H, et al. (2003) Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development. Mol Psychiatry 8: 19-29.
27. Mizuno M, Malta RS Jr, Nagano T, Nawa H, (2004) Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period. Ann N Y Acad Sci 1025: 612-618.
28. Tohmi M, Tsuda N, Mizuno M, Takei N, Frankland PW, et al. (2005) Distinct influences of neonatal epidermal growth factor challenge on adult neurobehavioral traits in four mouse strains. Behav Genet 35: 615-629.
29. Iwakura Y, Wang R, Abe Y, Piao YS, Shishido Y, et al. (2011) Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2). J Neurochem in press.
30. Tsuda N, Mizuno M, Yamanaka T, Komurasaki T, Yoshimoto M, et al. (2008) Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates. Brain Dev 30: 533-543.
31. Namba H, Nagano T, Iwakura Y, Xiong H, Jourdi H, et al. (2006) Transforming growth factor alpha attenuates the functional expression of AMPA receptors in cortical GABAergic neurons. Mol Cell Neurosci 31: 628-641.
32. Prensa L, Giménez-Amaya JM, Parent A, Bernácer J, Cebrián C, (2009) The nigrostriatal pathway: axonal collateralization and compartmental specificity. J Neural Transm Suppl 73: 49-58.
33. Rommelfanger KS, Wichmann T, (2010) Extrastriatal dopaminergic circuits of the Basal Ganglia. Front Neuroanat 4: 139.
34. Swerdlow NR, Geyer MA, Braff DL, (2001) Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194-215.
35. Brody SA, Dulawa SC, Conquet F, Geyer MA, (2004) Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors. Mol Psychiatry 9: 35-41.
36. Ogren SO, Fuxe K, (1988) D1- and D2-receptor antagonists induce catalepsy via different efferent striatal pathways. Neurosci Lett 85: 333-338.
37. Abe Y, Namba H, Zheng Y, Nawa H, (2009) In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons. Neuroscience 161: 95-110.
38. von Bohlen und Halbach O, Unsicker K, (2009) Neurotrophic support of midbrain dopaminergic neurons. Development and Engineering of Dopamine Neurons New York Springer Science pp. 73-77.
39. Solbrig M, Fallon J, Liplin I, (2004) Drawings of some other features of the SN-VTA, including dopamine transporter sites, cannabinoid receptors, and different nuclei and fiber tracts in the SN-VTA. In: Paxinos G, editors. The Rat Nervous System Australia: Academic Press.
40. Kornblum HI, Gall CM, Seroogy KB, Lauterborn JC, (1995) A subpopulation of striatal gabaergic neurons expresses the epidermal growth factor receptor. Neuroscience 69: 1025-1029.
41. Kato T, Kasai A, Mizuno M, Fengyi L, Shintani N, et al. (2011) Phenotypic characterization of transgenic mice overexpressing neuregulin-1. PLoS One 5: e14185.
42. Querejeta E, Delgado A, Valdiosera R, Erlij D, Aceves J, (2001) Intrapallidal D2 dopamine receptors control globus pallidus neuron activity in the rat. Neurosci Lett 300: 79-82.
43. Fuchs H, Hauber W, (2004) Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry. Exp Brain Res 154: 66-75.
44. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, et al. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432.
45. Smith Y, Bevan MD, Shink E, Bolam JP, (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86: 353-387.
46. Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, et al. (2003) Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci 23: 9078-9088.
47. Takahashi K, Nagai T, Kamei H, Maeda K, Matsuya T, et al. (2007) Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice. Biol Psychiatry 62: 148-157.
48. Qu Y, Swerdlow NR, Weber M, Stouffer D, Parsons LH, (2008) Quinelorane, a dopamine D3/D2 receptor agonist, reduces prepulse inhibition of startle and ventral pallidal GABA efflux: time course studies. Pharmacol Biochem Behav 90: 686-690.
49. Qu Y, Saint Marie RL, Breier MR, Ko D, Stouffer D, et al. (2009) Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats. Psychopharmacology (Berl) 207: 271-280.
50. Kodsi MH, Swerdlow NR, (1995) Prepulse inhibition in the rat is regulated by ventral and caudodorsal striato-pallidal circuitry. Behav Neurosci 109: 912-928.
51. Sotoyama H, Namba H, Takei N, Nawa H, (2007) Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating. Psychopharmacology (Berl) 191: 783-792.
52. Hauber W, Lutz S, (1999) Dopamine D1 or D2 receptor blockade in the globus pallidus produces akinesia in the rat. Behav Brain Res 106: 143-150.
53. Fuchs H, Hauber W, (2004) Changes in extracellular dopamine in the rat globus pallidus induced by typical and atypical antipsychotic drugs. Neurochem Int 45: 1029-1038.
54. Chiken S, Shashidharan P, Nambu A, (2008) Cortically evoked long-lasting inhibition of pallidal neurons in a transgenic mouse model of dystonia. J Neurosci 28: 13967-13977.
55. Bouali-Benazzouz R, Tai CH, Chetrit J, Benazzouz A, (2009) Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus. Neuroscience 164: 588-596.
56. Hokama H, Shenton ME, Nestor PG, Kikinis R, Levitt JJ, et al. (1995) Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study. Psychiatry Res 61: 209-229.
57. Gur RE, Maany V, Mozley PD, Swanson C, Bilker W, et al. (1998) Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia. Am J Psychiatry 155: 1711-1717.
58. Spinks R, Nopoulos P, Ward J, Fuller R, Magnotta VA, et al. (2005) Globus pallidus volume is related to symptom severity in neuroleptic naive patients with schizophrenia. Schizophr Res 73: 229-233.
59. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, et al. (2007) Structural analysis of the basal ganglia in schizophrenia. Schizophr Res 89: 59-71.
60. Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, et al. (2008) Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Biol Psychiatry 63: 475-483.
61. Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Noguchi H, et al. (2009) Abnormal microstructures of the basal ganglia in schizophrenia revealed by diffusion tensor imaging. World J Biol Psychiatry 10: 65-69.
62. Early TS, Reiman EM, Raichle ME, Spitznagel EL, (1987) Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc Natl Acad Sci USA 84: 561-563.
63. Menon V, Anagnoson RT, Glover GH, Pfefferbaum A, (2001) Functional magnetic resonance imaging evidence for disrupted basal ganglia function in schizophrenia. Am J Psychiatry 158: 646-649.
64. Iwakura Y, Nawa H, Sora I, Chao MV, (2008) Dopamine D1 receptor-induced signaling through TrkB receptors in striatal neurons. J Biol Chem 283: 15799-15806.
65. Goto Y, Grace AA, (2007) The dopamine system and the pathophysiology of schizophrenia: a basic science perspective. Int Rev Neurobiol 78: 41-68.
66. Toda M, Abi-Dargham A, (2007) Dopamine hypothesis of schizophrenia: making sense of it all. Curr Psychiatry Rep 9: 329-336.
67. Simpson EH, Kellendonk C, Kandel E, (2010) A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65: 585-596.
68. Borrell J, Vela JM, Arévalo-Martin A, Molina-Holgado E, Guaza C, (2002) Prenata immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia. Neuropsychopharmacology 26: 204-215.
69. Romero E, Guaza C, Castellano B, Borrell J, (2010) Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry 15: 372-383.
70. El-Khodor BF, Boksa P, (1997) Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth. Exp Neurol 145: 118-129.
71. Wakuda T, Matsuzaki H, Suzuki K, Iwata Y, Shinmura C, et al. (2008) Perinatal asphyxia reduces dentate granule cells and exacerbates methamphetamine-induced hyperlocomotion in adulthood. PLoS One 3: e3648.
72. Winter C, Djodari-Irani A, Sohr R, Morgenstern R, Feldon J, et al. (2009) Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol 12: 513-524.
73. Winter C, Reutiman TJ, Folsom TD, Sohr R, Wolf RJ, et al. (2008) Dopamine and serotonin levels following prenatal viral infection in mouse-implications for psychiatric disorders such as schizophrenia and autism. Eur Neuropsychopharmacol 18: 712-716.
74. Vuillermot S, Weber L, Feldon J, Meyer U, (2010) A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci 30: 1270-1287.
75. Paxinos G, Watson C, (1986) The Rat Brain in Stereotaxic Coordinates San Diego Academic Press.
76. Marchese G, Casti P, Ruiu S, Saba P, Sanna A, et al. (2003) Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications. Br J Pharmacol 140: 520-526.